1. Liebman HA, Furie BC, Tong MJ, Blanchard RA, Lo K-J, Lee S-D, Coleman MS, Furie B: Des-?-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 310:1427?1431, 1984
2. Motohara K, Kuroki Y, Kan H, Endo F, Matsuda I: Detection of vitamin K deficiency by use of an enzymelinked immunosorbent assay for circulating abnormal prothrombin. Pediatr Res 19:354?357, 1985
3. Fujiyama S, Morishita T, Yoshida K, Harada T, Kojima N, Hashiguchi O, Sagara K, Motohara K, Matsuda I: Plasma PIVKA-II levels in various liver diseases: With special reference to plasma PIVKA-II as a marker of hepatocellular carcinoma. Jpn J Gastroenterol 82:135, 1985
4. Fujiyama S, Morishita T, Sagara K, Sato T, Motohara K, Matsuda I: Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma. Hepato-gastroenterol 33:201?205, 1986
5. Fujiyama S, Morishita T, Hashiguchi O, Sato T: Plasma abnormal prothrombin (des-?-carboxy prothrombin) as a marker of hepatocellular carcinoma. Cancer 61:1621?1628, 1988